Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 09-2004 | 09-2003 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,442 | -4 | -346 | -433 | 4,947 |
| Depreciation Amortization | 12 | N/A | 1 | 1 | 8 |
| Accounts payable and accrued liabilities | 163 | N/A | -3 | -16 | -95 |
| Other Working Capital | 422 | N/A | 3 | -13 | -90 |
| Other Operating Activity | -121 | 0 | 3 | 16 | 121 |
| Operating Cash Flow | $-4,967 | $-4 | $-342 | $-446 | $4,891 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 27 | 24 | 26 |
| PPE Investments | -384 | N/A | 0 | -1 | N/A |
| Investing Cash Flow | $-384 | $N/A | $27 | $23 | $26 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 500 |
| Debt Issued | 63 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 25,562 | 17 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | N/A | -1,344 | N/A | -217 |
| Other Financing Activity | 1,500 | 0 | 0 | 0 | -500 |
| Financing Cash Flow | $27,125 | $17 | $-1,344 | $N/A | $-217 |
| Beginning Cash Position | 13 | N/A | 4,346 | 4,769 | 69 |
| End Cash Position | 21,788 | 13 | 2,686 | 4,346 | 4,769 |
| Net Cash Flow | $21,775 | $13 | $-1,659 | $-423 | $4,700 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,967 | -4 | -342 | -446 | 4,891 |
| Capital Expenditure | -384 | N/A | 0 | -1 | N/A |
| Free Cash Flow | -5,350 | -4 | -342 | -447 | 4,891 |